Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Discover ways to maximize earnings for debt repayment. Efficient strategies can lead to faster debt elimination.
19,968 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Johnson & Johnson and Coca-Cola posted strong Q1 2026 results as markets rotate toward defensive plays. The big quest...
An unusual trading day put Lucid Group in the spotlight after rumors swirled about bankruptcy or going private. Learn...
A high-profile insider move by Pinterest’s leadership drew attention from investors. This deep dive explains what the...
Insider selling often triggers headlines, but it isn’t a crystal ball for stock moves. This guide shows how to evalua...
A little-known dividend-focused ETF has boosted its quarterly payout 38% over three years, delivering steady income i...
Airbnb embraces AI as a growth engine, with Chesky warning competitors to adapt quickly or risk falling behind, as th...
Institutional moves can reveal where smart money is flowing. Learn why highmark wealth management buys Axogen stock, ...
Greycroft increased its Sportradar stake in a year where the stock fell sharply, illustrating how big investors respo...
When Berkshire Hathaway's Greg Abel takes the stage as Buffett’s successor, the market watches not for flashy moves b...
SoFi shares jump after Anthony Noto buys $1 million in stock, a move traders say signals backing the growth plan. The...
With burnout on the rise in early 2026, workers seek structured ways to reduce load without leaving their jobs. Inves...